SI-BONE, Inc. (SIBN)
SIBN Stock Price Chart
Explore SI-BONE, Inc. interactive price chart. Choose custom timeframes to analyze SIBN price movements and trends.
SIBN Company Profile
Discover essential business fundamentals and corporate details for SI-BONE, Inc. (SIBN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
17 Oct 2018
Employees
349.00
Website
https://si-bone.comCEO
Laura A. Francis MBA
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Financial Timeline
Browse a chronological timeline of SI-BONE, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Nov 2026
Upcoming earnings on 3 Aug 2026
Upcoming earnings on 4 May 2026
Upcoming earnings on 12 Jan 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.17.
Earnings released on 4 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%, while revenue for the quarter reached $48.63M , beating expectations by +4.19%.
Earnings released on 5 May 2025
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $47.29M , beating expectations by +1.24%.
Earnings released on 24 Feb 2025
EPS came in at -$0.11 surpassing the estimated -$0.15 by +24.38%, while revenue for the quarter reached $49.00M , beating expectations by +1.80%.
Earnings released on 12 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $40.34M , missing expectations by -13.97%.
Earnings released on 5 Aug 2024
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $39.97M , beating expectations by +4.30%.
Earnings released on 6 May 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%, while revenue for the quarter reached $37.87M , beating expectations by +3.77%.
Earnings released on 26 Feb 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%, while revenue for the quarter reached $38.86M , beating expectations by +3.32%.
Earnings released on 6 Nov 2023
EPS came in at -$0.25 surpassing the estimated -$0.33 by +24.24%, while revenue for the quarter reached $34.01M , missing expectations by -6.91%.
Earnings released on 7 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.41 by +26.83%, while revenue for the quarter reached $33.31M , beating expectations by +6.71%.
Earnings released on 1 May 2023
EPS came in at -$0.32 surpassing the estimated -$0.41 by +21.95%, while revenue for the quarter reached $32.71M , beating expectations by +5.37%.
Earnings released on 27 Feb 2023
EPS came in at -$0.32 surpassing the estimated -$0.42 by +23.81%, while revenue for the quarter reached $31.95M , beating expectations by +1.43%.
Earnings released on 7 Nov 2022
EPS came in at -$0.41 surpassing the estimated -$0.45 by +8.89%, while revenue for the quarter reached $26.43M , missing expectations by 0.00%.
Earnings released on 8 Aug 2022
EPS came in at -$0.54 falling short of the estimated -$0.49 by -10.20%, while revenue for the quarter reached $25.59M , beating expectations by +1.63%.
Earnings released on 9 May 2022
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%, while revenue for the quarter reached $22.44M , beating expectations by +2.61%.
Earnings released on 28 Feb 2022
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%, while revenue for the quarter reached $25.23M , beating expectations by +2.12%.
Earnings released on 8 Nov 2021
EPS came in at -$0.48 falling short of the estimated -$0.41 by -17.07%, while revenue for the quarter reached $22.29M , missing expectations by -9.22%.
Earnings released on 2 Aug 2021
EPS came in at -$0.42 falling short of the estimated -$0.39 by -7.69%, while revenue for the quarter reached $22.19M , meeting expectations.
Earnings released on 3 May 2021
EPS came in at -$0.37 surpassing the estimated -$0.38 by +2.63%, while revenue for the quarter reached $20.44M , missing expectations by -6.98%.
Earnings released on 8 Mar 2021
EPS came in at -$0.28 surpassing the estimated -$0.30 by +6.67%, while revenue for the quarter reached $22.14M .
Earnings released on 2 Nov 2020
EPS came in at -$0.33 surpassing the estimated -$0.38 by +13.16%, while revenue for the quarter reached $20.37M , missing expectations by -15.38%.
SIBN Stock Performance
Access detailed SIBN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.